WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Complicated Urinary Tract Infections - Efficacy Framework v9, Microbiologically Evaluable Population (ME) classified by Country/Region, Microbiological Outcomes includes Indeterminate, Study Drug | Comparator has value for Dosage, Blood Culture Tests can be positive, Pathogen Species measures Colony Forming Unit Value, Patient may have Complicating Factors, Microbiological Eradication Rate calculated by Microbiological Eradication Rate Formula, Microbiological Eradication Rate measured in Microbiological Intent to Treat Population (MITT), Defined Time Point includes LTFU Visit, Ascending example Ascending Pyelonephritis, Route of Infection includes Ascending, Defined Time Point includes TOC Visit, Clinical Outcomes assessed at Defined Time Point, Study Drug | Comparator subjected to Susceptability Testing, Defined Time Point includes EOT Visit, Study Drug | Comparator may be administered with Concomitant Antibiotic, Concepts (e.g. Graft survival) are denoted by solid round-edged rectangle, Defined Time Point includes EOT Visit, Microbiological Outcomes classified by Sponsor, Observation or Assessment is used to monitor the state of Physiolgoical Process